← Back to Search

N/A

Two passes performed during EUS-FNB of pancreatic adenocarcinoma for Pancreatic Adenocarcinoma

N/A
Waitlist Available
Led By Ji Young Bang, MD MPH
Research Sponsored by Orlando Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial is testing how many times a needle should be passed through the pancreas to get a tissue sample for genetic testing.

Eligible Conditions
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of ability to perform successful molecular profiling in core tissue obtained during EUS-guided fine needle biopsy
Secondary outcome measures
Number of actionable mutations detected on molecular profiling
Rate of procedure-related adverse events
Rate of technical success
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Two passes performed during EUS-FNB of pancreatic adenocarcinomaActive Control1 Intervention
Once the pancreatic mass is identified on endoscopic ultrasound examination, total of two passes will be performed during find needle biopsy and placed in 10% formalin for processing for molecular profiling.
Group II: Three passes performed during EUS-FNB of pancreatic adenocarcinomaActive Control1 Intervention
Once the pancreatic mass is identified on endoscopic ultrasound examination, total of three passes will be performed during find needle biopsy and placed in 10% formalin for processing for molecular profiling.

Find a Location

Who is running the clinical trial?

Orlando Health, Inc.Lead Sponsor
27 Previous Clinical Trials
13,343 Total Patients Enrolled
Ji Young Bang, MD MPHPrincipal InvestigatorOrlando Health
4 Previous Clinical Trials
1,770 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this medical investigation still open to participants?

"According to the clinicaltrials.gov webpage, this medical trial is currently in recruitment mode, having been originally listed on August 18th 2021 and last edited October 4th 2022."

Answered by AI

How many individuals have enrolled in this research endeavor?

"Affirmative. The clinicaltrials.gov website exhibits that this medical experiment, which was first proclaimed on the 18th of August 2021, is actively recruiting individuals to participate in the study. 40 volunteers are being recruited from a single site."

Answered by AI
~9 spots leftby Mar 2025